AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

RMD · NYSE · Medical - Instruments & Supplies

ResMed (RMD)

Builds connected sleep-apnea devices, masks, ventilators, and home-care software.

$221.97

After hours0.00 (0.00%)

At close$221.97(−0.73%)

In millions of USD, except per-share figures

In millions	Q1 FY24Sep 2023	Q2 FY24Dec 2023	Q3 FY24Mar 2024	Q4 FY24Jun 2024	Q1 FY25Sep 2024	Q2 FY25Dec 2024	Q3 FY25Mar 2025	Q4 FY25Jun 2025	Q1 FY26Sep 2025	Q2 FY26Dec 2025	Q3 FY26Mar 2026	Q4 FY26Jun 2026
Revenue	1,102	1,163	1,197	1,223	1,225	1,282	1,292	1,348	1,336	1,423	1,431	1,464
Cost of revenue	502	493	515	519	507	531	525	528	515	538	540	602
Gross profit	600	669	682	704	717	751	766	820	821	885	891	861
	311	394	307	323	330	334	340	366	374	387	391	413
Research & development	76	74	77	81	80	81	84	86	87	91	94	106
Selling, general & administrative	223	222	230	242	239	242	245	265	259	278	280	0
Other expenses	12	98	0	0	11	11	11	14	28	18	17	307
Operating income	289	275	375	381	387	417	426	455	447	498	500	449
	−17	−16	1	−23	−4	1	−9	4	0	−1	3	25
Interest income	0	0	3	4	0	0	1	6	0	0	0	21
Interest expense	15	14	14	10	6	5	3	0	9	8	12	0
Other non-operating income	2	−64	−15	74	−2	−6	9	−2	−9	−7	−15	−25
Income before tax	272	259	375	358	383	418	418	458	447	496	502	474
Income tax expense	53	51	75	65	72	74	53	78	98	104	104	91
Net income from continuing operations	219	209	300	292	311	345	365	380	349	393	399	383
Net income	219	209	300	292	311	345	365	380	349	393	399	383
EPS, basic	$1.49	$1.42	$2.04	$1.99	$2.12	$2.35	$2.49	$2.59	$2.38	$2.69	$2.72	$2.65
EPS, diluted	$1.49	$1.42	$2.04	$1.98	$2.11	$2.34	$2.48	$2.58	$2.37	$2.68	$2.71	$2.64
Weighted average shares, basic	147	147	147	147	147	147	147	146	146	146	146	145
Weighted average shares, diluted	147	148	147	148	148	148	147	147	147	147	147	145
EBITDA	341	377	444	362	443	479	470	532	503	566	584	493
Depreciation & amortization	53	38	55	55	54	56	52	74	48	62	69	19
EBIT	287	339	390	308	389	423	418	458	456	504	515	474